Literature DB >> 23303565

Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.

J Julie Kim1, Takeshi Kurita, Serdar E Bulun.   

Abstract

Progesterone receptor (PR) mediates the actions of the ovarian steroid progesterone, which together with estradiol regulates gonadotropin secretion, prepares the endometrium for implantation, maintains pregnancy, and differentiates breast tissue. Separation of estrogen and progesterone actions in hormone-responsive tissues remains a challenge. Pathologies of the uterus and breast, including endometrial cancer, endometriosis, uterine fibroids, and breast cancer, are highly associated with estrogen, considered to be the mitogenic factor. Emerging evidence supports distinct roles of progesterone and its influence on the pathogenesis of these diseases. Progesterone antagonizes estrogen-driven growth in the endometrium, and insufficient progesterone action strikingly increases the risk of endometrial cancer. In endometriosis, eutopic and ectopic tissues do not respond sufficiently to progesterone and are considered to be progesterone-resistant, which contributes to proliferation and survival. In uterine fibroids, progesterone promotes growth by increasing proliferation, cellular hypertrophy, and deposition of extracellular matrix. In normal mammary tissue and breast cancer, progesterone is pro-proliferative and carcinogenic. A key difference between these tissues that could explain the diverse effects of progesterone is the paracrine interactions of PR-expressing stroma and epithelium. Normal endometrium is a mucosa containing large quantities of distinct stromal cells with abundant PR, which influences epithelial cell proliferation and differentiation and protects against carcinogenic transformation. In contrast, the primary target cells of progesterone in the breast and fibroids are the mammary epithelial cells and the leiomyoma cells, which lack specifically organized stromal components with significant PR expression. This review provides a unifying perspective for the diverse effects of progesterone across human tissues and diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23303565      PMCID: PMC3565104          DOI: 10.1210/er.2012-1043

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  320 in total

1.  A novel LacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development.

Authors:  Preeti M Ismail; Jie Li; Francesco J DeMayo; Bert W O'Malley; John P Lydon
Journal:  Mol Endocrinol       Date:  2002-11

2.  Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2.

Authors:  S Yang; Z Fang; B Gurates; M Tamura; J Miller; K Ferrer; S E Bulun
Journal:  Mol Endocrinol       Date:  2001-12

3.  Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17beta-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism.

Authors:  You-Hong Cheng; Ayse Imir; Veysel Fenkci; Mehmet Bertan Yilmaz; Serdar E Bulun
Journal:  Am J Obstet Gynecol       Date:  2007-04       Impact factor: 8.661

4.  Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial.

Authors:  Kevin Fiscella; Steven H Eisinger; Sean Meldrum; Changyong Feng; Susan G Fisher; David S Guzick
Journal:  Obstet Gynecol       Date:  2006-12       Impact factor: 7.661

5.  In utero exposures and the incidence of endometriosis.

Authors:  Stacey A Missmer; Susan E Hankinson; Donna Spiegelman; Robert L Barbieri; Karin B Michels; David J Hunter
Journal:  Fertil Steril       Date:  2004-12       Impact factor: 7.329

6.  Steroid hormone receptor status of mouse mammary stem cells.

Authors:  Marie-Liesse Asselin-Labat; Mark Shackleton; John Stingl; François Vaillant; Natasha C Forrest; Connie J Eaves; Jane E Visvader; Geoffrey J Lindeman
Journal:  J Natl Cancer Inst       Date:  2006-07-19       Impact factor: 13.506

7.  Longitudinal evaluation of uterine myoma growth during pregnancy. A sonographic study.

Authors:  P Rosati; C Exacoustòs; S Mancuso
Journal:  J Ultrasound Med       Date:  1992-10       Impact factor: 2.153

Review 8.  Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives.

Authors:  Birgit Gellersen; Ivo A Brosens; Jan J Brosens
Journal:  Semin Reprod Med       Date:  2007-11       Impact factor: 1.303

9.  Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle.

Authors:  E A Stewart; A J Friedman; K Peck; R A Nowak
Journal:  J Clin Endocrinol Metab       Date:  1994-09       Impact factor: 5.958

10.  A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.

Authors:  P Vercellini; L Trespidi; A Colombo; N Vendola; M Marchini; P G Crosignani
Journal:  Fertil Steril       Date:  1993-07       Impact factor: 7.329

View more
  164 in total

1.  Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.

Authors:  Kristie Mozzachio; Alicia B Moore; Grace E Kissling; Darlene Dixon
Journal:  Toxicol Pathol       Date:  2015-12-20       Impact factor: 1.902

Review 2.  Role of nuclear receptors in blastocyst implantation.

Authors:  Y M Vasquez; F J DeMayo
Journal:  Semin Cell Dev Biol       Date:  2013-08-28       Impact factor: 7.727

3.  Targeting progesterone signaling prevents metastatic ovarian cancer.

Authors:  Olga Kim; Eun Young Park; Sun Young Kwon; Sojin Shin; Robert E Emerson; Yong-Hyun Shin; Francesco J DeMayo; John P Lydon; Donna M Coffey; Shannon M Hawkins; Lawrence A Quilliam; Dong-Joo Cheon; Facundo M Fernández; Kenneth P Nephew; Adam R Karpf; Martin Widschwendter; Anil K Sood; Robert C Bast; Andrew K Godwin; Kathy D Miller; Chi-Heum Cho; Jaeyeon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-01       Impact factor: 11.205

4.  Progesterone antagonizes the positive influence of estrogen on Chlamydia trachomatis serovar E in an Ishikawa/SHT-290 co-culture model.

Authors:  Jennifer Kintner; Robert V Schoborg; Priscilla B Wyrick; Jennifer V Hall
Journal:  Pathog Dis       Date:  2015-02-26       Impact factor: 3.166

Review 5.  Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.

Authors:  Mostafa A Borahay; Ayman Al-Hendy; Gokhan S Kilic; Darren Boehning
Journal:  Mol Med       Date:  2015-04-13       Impact factor: 6.354

Review 6.  Role of the steroidogenic acute regulatory protein in health and disease.

Authors:  Pulak R Manna; Cloyce L Stetson; Andrzej T Slominski; Kevin Pruitt
Journal:  Endocrine       Date:  2015-08-14       Impact factor: 3.633

Review 7.  Endometriosis and nuclear receptors.

Authors:  Bahar D Yilmaz; Serdar E Bulun
Journal:  Hum Reprod Update       Date:  2019-07-01       Impact factor: 15.610

Review 8.  Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus.

Authors:  Margeaux Wetendorf; Francesco J DeMayo
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

9.  Bisphenol A impairs decidualization of human uterine stromal fibroblasts.

Authors:  Mark R Olson; Renwei Su; Jodi A Flaws; Asgerally T Fazleabas
Journal:  Reprod Toxicol       Date:  2017-07-17       Impact factor: 3.143

10.  Uterine function in the mouse requires speckle-type poz protein.

Authors:  Lan Hai; Maria M Szwarc; Bin He; David M Lonard; Ramakrishna Kommagani; Francesco J DeMayo; John P Lydon
Journal:  Biol Reprod       Date:  2018-06-01       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.